TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35488452

Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy
Number of subjects: 1726

Group type: EXPERIMENTAL
Intervention: Cognitive‐Behavioral Therapy
Number of subjects: 1726

Group type: EXPERIMENTAL
Intervention: Twelve‐Step Facilitation
Number of subjects: 1726

Group type: COMPARATOR
Intervention: URICA (University of Rhode Island Change Assessment Scale)
Number of subjects: 1726
Study: 613877316

Group type: EXPERIMENTAL
Intervention: Low-stress condition
Number of subjects: 39

Group type: COMPARATOR
Intervention: High-stress condition
Number of subjects: 39

Group type: COMPARATOR
Intervention: High-stress condition (women)
Number of subjects: 39

Group type: COMPARATOR
Intervention: High-stress condition (men)
Number of subjects: 39
Study: 37290207

Group type: EXPERIMENTAL
Intervention: NEPA + no further DEX (DEX1)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: NEPA + oral low-dose DEX (4 mg) on days 2-3 (DEX3)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: NEPA + standard DEX (4 mg twice daily) on days 2-4 (DEX4)
Number of subjects: 107
Study: 33896356

Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg/2 mL pre-filled syringe (PFS)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 214
Study: 33980778

Group type: EXPERIMENTAL
Intervention: Writing and reading aloud positive events
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (usual work)
Number of subjects: 57
Study: 33641430

Group type: EXPERIMENTAL
Intervention: 15 mg/kg intravenous tranexamic acid (TXA) diluted in 100 ml normal saline (NS)
Number of subjects: 165

Group type: COMPARATOR
Intervention: IV placebo 100 ml normal saline (NS)
Number of subjects: 165
Study: 32520387

Group type: EXPERIMENTAL
Intervention: Long pulse-width Holmium-YAG laser lithotripsy
Number of subjects: 32

Group type: COMPARATOR
Intervention: Short pulse-width Holmium-YAG laser lithotripsy
Number of subjects: 32
Study: 34016120

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 9340

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9340
Study: 32124422

Group type: EXPERIMENTAL
Intervention: Multimodal intervention including adapted tango, music therapy, social activities, cognitive intervention, and psycho-education for 6 months.
Number of subjects: 300

Group type: COMPARATOR
Intervention: Psycho-education and advice on healthy lifestyle for 6 months (Control group).
Number of subjects: 300
Study: 33159177

Group type: EXPERIMENTAL
Intervention: Extended C‐ILMP (EC‐ILMP)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional internal limiting membrane peeling (C‐ILMP)
Number of subjects: 100
Study: 32977202

Group type: EXPERIMENTAL
Intervention: Fitspiration images
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Thinspiration images
Number of subjects: 223

Group type: COMPARATOR
Intervention: Neutral images
Number of subjects: 223
Study: 34142664

Group type: EXPERIMENTAL
Intervention: Surgery (72% of patients, 126 of 174)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Casting (28% of patients, 48 of 174)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Surgery (when prioritizing ROM over pain reduction more than 80:20)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Surgery (when prioritizing grip strength over pain reduction more than 70:30)
Number of subjects: 174
Study: 35527256

Group type: EXPERIMENTAL
Intervention: Surgical mask
Number of subjects: 216

Group type: COMPARATOR
Intervention: Cloth mask
Number of subjects: 216
Study: 32081238

Group type: EXPERIMENTAL
Intervention: Zilver PTX stent
Number of subjects: 186

Group type: COMPARATOR
Intervention: Misago stent
Number of subjects: 186
Study: 36794542

Group type: EXPERIMENTAL
Intervention: Regenerative limb salvage (rLS) using dehydrated human chorion amnion membrane (dHACM)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Flap-based limb salvage (fLS)
Number of subjects: 39
Study: 33660033

Group type: EXPERIMENTAL
Intervention: HIV-infected individuals
Number of subjects: 300

Group type: COMPARATOR
Intervention: HIV-uninfected individuals
Number of subjects: 300
Study: 35141886

Group type: EXPERIMENTAL
Intervention: Early placement of hormonal IUD (LNG-IUS, Mirena®) within 48 hours after delivery
Number of subjects: 101

Group type: COMPARATOR
Intervention: Standard placement of hormonal IUD (LNG-IUS, Mirena®) 6–8 weeks postpartum
Number of subjects: 101
Study: 34496721

Group type: EXPERIMENTAL
Intervention: Traction-manipulation protocol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 32487507

Group type: EXPERIMENTAL
Intervention: 10 1-mg hydromorphone tablets or no hydromorphone if no opioids were required in hospital
Number of subjects: 40

Group type: COMPARATOR
Intervention: 20 1-mg hydromorphone tablets (standard post-cesarean opioid prescription)
Number of subjects: 40
Study: 35935409

Group type: EXPERIMENTAL
Intervention: Tapered discontinuation of antipsychotic medication
Number of subjects: 29

Group type: COMPARATOR
Intervention: Maintenance treatment with antipsychotic medication
Number of subjects: 29
Study: 32016928

Group type: EXPERIMENTAL
Intervention: Tranexamic Acid (TXA) - bolus dose of 10 mg/kg followed by 8 hours continuous infusion of 3 mg/kg/h
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Tranexamic Acid (TXA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 35102364

Group type: EXPERIMENTAL
Intervention: Gastric hop extract (500 mg, quick-release capsules)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Duodenal hop extract (500 mg, delayed-release capsules)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 36203149

Group type: EXPERIMENTAL
Intervention: RTS,S/AS01E malaria vaccine (primary series and two seasonal boosters) and seasonal malaria chemoprevention (four monthly cycles per year)
Number of subjects: 5920

Group type: COMPARATOR
Intervention: Seasonal malaria chemoprevention (SMC)
Number of subjects: 5920

Group type: COMPARATOR
Intervention: RTS,S/AS01E malaria vaccine alone
Number of subjects: 5920

Group type: EXPERIMENTAL
Intervention: Combination of SMC and RTS,S/AS01E
Number of subjects: 5920
Study: 33759752

Group type: EXPERIMENTAL
Intervention: Inpatient pulmonary rehabilitation (PR) for 3 weeks
Number of subjects: 412

Group type: COMPARATOR
Intervention: Waiting-list control group (CG)
Number of subjects: 412
Study: 36240478

Group type: EXPERIMENTAL
Intervention: Rogaratinib (800 mg orally twice daily, 3-week cycles)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Chemotherapy (docetaxel 75 mg/m2, paclitaxel 175 mg/m2, or vinflunine 320 mg/m2 intravenously once every 3 weeks)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Rogaratinib (in exploratory analysis)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Chemotherapy (in exploratory analysis)
Number of subjects: 175
Study: 34081408

Group type: EXPERIMENTAL
Intervention: Recombinant tetanus vaccine (TeNT-Hc 10/20/30 µg)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Tetanus toxoid (TT) vaccine
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 36254383

Group type: EXPERIMENTAL
Intervention: Assembly-type guide device
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: C-shape device
Number of subjects: 54

Group type: COMPARATOR
Intervention: Free-hand technique
Number of subjects: 54
Study: 33268022

Group type: EXPERIMENTAL
Intervention: Sertraline plus Olanzapine
Number of subjects: 269

Group type: COMPARATOR
Intervention: Sertraline plus Placebo
Number of subjects: 269
Study: 35488323

Group type: EXPERIMENTAL
Intervention: G-CBT + usual care
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: MFG + usual care
Number of subjects: 90

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 90
Study: 34919616

Group type: EXPERIMENTAL
Intervention: Immediate Restoration (IR)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Delayed Restoration (DR)
Number of subjects: 40
Study: 33377537

Group type: EXPERIMENTAL
Intervention: Odds and hazard ratios
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Redefined odds and hazards ratio causal estimands
Number of subjects: 0
Study: 34737784

Group type: EXPERIMENTAL
Intervention: Interactive rehabilitation care
Number of subjects: 120
Study: 32623626

Group type: EXPERIMENTAL
Intervention: Triple P‐Positive Parenting Program
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (general population mothers)
Number of subjects: 240
Study: 35538523

Group type: EXPERIMENTAL
Intervention: Educational intervention through social network within 16 training sessions related to physical activity and nutrition in 8 weeks
Number of subjects: 90
Study: 34726760

Group type: EXPERIMENTAL
Intervention: In-hospital P.A.R.T.Y. program
Number of subjects: 952

Group type: EXPERIMENTAL
Intervention: On-base P.A.R.T.Y. program
Number of subjects: 952

Group type: COMPARATOR
Intervention: Control group (annual alcohol and other drugs awareness training only)
Number of subjects: 952
Study: 34424869

Group type: EXPERIMENTAL
Intervention: Pregabalin (2 mg/kg, twice daily preoperatively and for 5 days postoperatively)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 64
Study: 32094154

Group type: EXPERIMENTAL
Intervention: Community intervention programme (three monthly community clinics treating wet cough with prolonged antibiotics)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Usual pathway of parent‐initiated healthcare access (control)
Number of subjects: 400
Study: 36457648

Group type: EXPERIMENTAL
Intervention: SLNB (Sentinel Lymph Node Biopsy)
Number of subjects: 5154

Group type: COMPARATOR
Intervention: No SLNB
Number of subjects: 5154

Group type: EXPERIMENTAL
Intervention: ALND (Axillary Lymph Node Dissection)
Number of subjects: 5154
Study: 33676526

Group type: EXPERIMENTAL
Intervention: Ultra-congruent fixed (UC) implant
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: UCR Columbus Total Knee System
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Low congruent fixed (CR DD) implant
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (9 participants)
Number of subjects: 24
Study: 32629997

Group type: COMPARATOR
Intervention: Antenatal intervention for Class III women
Number of subjects: 1555

Group type: COMPARATOR
Intervention: Antenatal intervention for Class I and II women
Number of subjects: 1555
Study: 36004820

Group type: EXPERIMENTAL
Intervention: Balance Training (BT)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 28
Study: 34300310

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.4 µg/kg/h)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control
Number of subjects: 56
Study: 32621374

Group type: EXPERIMENTAL
Intervention: Point-of-care testing (POCT) analyzers implemented in the ED
Number of subjects: 23231

Group type: COMPARATOR
Intervention: Central laboratory
Number of subjects: 23231
Study: 35162447

Group type: EXPERIMENTAL
Intervention: FLOSS intervention
Number of subjects: 20

Group type: COMPARATOR
Intervention: ELA control
Number of subjects: 20
Study: 33307633

Group type: EXPERIMENTAL
Intervention: Transversalis fascia plane (TFP) block with 0.4 mL/kg bupivacaine 0.25%
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group with 0.9% saline
Number of subjects: 40
Study: 35189286

Group type: EXPERIMENTAL
Intervention: Medial-Stabilized (MS) device
Number of subjects: 200

Group type: COMPARATOR
Intervention: Posterior-Stabilized (PS) device
Number of subjects: 200
Study: 34430755

Group type: EXPERIMENTAL
Intervention: Bystander-based violence intervention 'Green Dot'
Number of subjects: 25
Study: 35552492

Group type: EXPERIMENTAL
Intervention: Nutrition, hygiene, and stimulation education intervention among mothers
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Microbiota
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Intervention and microbiota
Number of subjects: 344
Study: 32818600

Group type: EXPERIMENTAL
Intervention: Musically trained subjects
Number of subjects: 0

Group type: COMPARATOR
Intervention: Musically untrained subjects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Visual stimulus contrast focusing on visual motion percept of moving fingers on piano keys in trained subjects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Duration of training in trained subjects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quantitative analysis of individual brain volumes in trained subjects
Number of subjects: 0
Study: 35362101

Group type: EXPERIMENTAL
Intervention: Ibudilast
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 32920228

Group type: EXPERIMENTAL
Intervention: 70‐min PNE lecture
Number of subjects: 37

Group type: COMPARATOR
Intervention: 70‐min control education
Number of subjects: 37
Study: 35157638

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Strength exercise
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 0
Study: 34288127

Group type: EXPERIMENTAL
Intervention: HEPA air cleaners
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control
Number of subjects: 71
Study: 32325778

Group type: EXPERIMENTAL
Intervention: Omega-3 and Vitamin D supplement (510 mg DHA, 344 mg EPA, 1000 IU vitamin D)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35226749

Group type: EXPERIMENTAL
Intervention: Preheated resin composite (RC)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Nonheated resin composite (RC)
Number of subjects: 35
Study: 33211204

Group type: EXPERIMENTAL
Intervention: Warm temperature group
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Medium temperature group
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Cool temperature group
Number of subjects: 105
Study: 32112772

Group type: EXPERIMENTAL
Intervention: Scheimpflug imaging pachymetry and posterior elevation maps
Number of subjects: 0
Study: 35419807

Group type: EXPERIMENTAL
Intervention: ASP8302 (100 mg, oral, once daily for 4 weeks)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: ASP8302
Number of subjects: 135
Study: 33482782

Group type: EXPERIMENTAL
Intervention: Chronic musculoskeletal pain (CMP) patients
Number of subjects: 969

Group type: COMPARATOR
Intervention: Patients without chronic musculoskeletal pain (no CMP)
Number of subjects: 969
Study: 34739075

Group type: EXPERIMENTAL
Intervention: venetoclax-azacitidine
Number of subjects: 37

Group type: COMPARATOR
Intervention: placebo-azacitidine
Number of subjects: 37
Study: 33935055

Group type: EXPERIMENTAL
Intervention: Clinical Pilates exercises (CPE)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 55
Study: 35139809

Group type: EXPERIMENTAL
Intervention: Group transdiagnostic cognitive-behavioural therapy (tCBT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Individual transdiagnostic cognitive-behavioural therapy (tCBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 0
Study: 36314204

Group type: EXPERIMENTAL
Intervention: Mindful Awareness Practice (MAP)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Health Education Program (HEP)
Number of subjects: 55
Study: 32841683

Group type: EXPERIMENTAL
Intervention: Porcine liver decomposition product (PLDP) - 4 capsules for 4 weeks
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo - 4 capsules for 4 weeks
Number of subjects: 58
Study: 36416089

Group type: EXPERIMENTAL
Intervention: Nintendo Wii Fit
Number of subjects: 23

Group type: COMPARATOR
Intervention: Home-based fun video exercises
Number of subjects: 23
Study: 33910419

Group type: COMPARATOR
Intervention: TLR4 Asp299Gly genotype
Number of subjects: 84

Group type: COMPARATOR
Intervention: TLR4 Thr399Ile genotype
Number of subjects: 84

Group type: COMPARATOR
Intervention: TLR9 T1237C genotype
Number of subjects: 84
Study: 32281095

Group type: EXPERIMENTAL
Intervention: 1% lidocaine solution administered via new catheter
Number of subjects: 252

Group type: COMPARATOR
Intervention: Lidocaine gel
Number of subjects: 252
Study: 35124338

Group type: EXPERIMENTAL
Intervention: NAVA
Number of subjects: 46

Group type: COMPARATOR
Intervention: Conventional mechanical ventilation
Number of subjects: 46
Study: 33958243

Group type: EXPERIMENTAL
Intervention: Butorphanol in combination with dexmedetomidine
Number of subjects: 44

Group type: COMPARATOR
Intervention: Butorphanol combined with saline (control group)
Number of subjects: 44
Study: 32443302

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine-ketamine (1 mg/kg ketamine, 1 μg/kg dexmedetomidine loading dose over 10 minutes, followed by infusion at 0.6 μg/kg/h for 20 minutes)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Dexmedetomidine-fentanyl (1 μg/kg fentanyl, 1 μg/kg dexmedetomidine loading dose over 10 minutes, followed by infusion at 0.6 μg/kg/h for 20 minutes)
Number of subjects: 46
Study: 35378136

Group type: EXPERIMENTAL
Intervention: G‐POEM (Gastric peroral endoscopic myotomy)
Number of subjects: 374
Study: 34236392

Group type: EXPERIMENTAL
Intervention: Nitrate-rich vegetable group (n=25)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Beetroot juice group (n=26)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group (n=26)
Number of subjects: 77
Study: 32468448

Group type: EXPERIMENTAL
Intervention: Ultra Rapid Lispro (URLi)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Humalog® (Lispro)
Number of subjects: 38
Study: 35975659

Group type: EXPERIMENTAL
Intervention: Activity advice and social support as an add-on to usual care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 0
Study: 34018344

Group type: EXPERIMENTAL
Intervention: Mesdopetam (IRL790) single dose (up to 120 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mesdopetam (IRL790) multiple doses (up to 80 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mesdopetam (IRL790)
Number of subjects: 0
Study: 32951002

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (OT)
Number of subjects: 45
Study: 32192396

Group type: EXPERIMENTAL
Intervention: Oral agar (600 mg/kg/day dissolved in 10 ml distilled water, twice daily until TSB decreased to 7 mg/dl)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Oral agar plus phototherapy
Number of subjects: 160

Group type: COMPARATOR
Intervention: Phototherapy alone
Number of subjects: 160
Study: 34580498

Group type: EXPERIMENTAL
Intervention: Mobilisation with movement
Number of subjects: 34

Group type: COMPARATOR
Intervention: Mulligan knee taping
Number of subjects: 34

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 34
Study: 32366963

Group type: EXPERIMENTAL
Intervention: Higher BMI (kg/m2)
Number of subjects: 675697

Group type: EXPERIMENTAL
Intervention: Mendelian randomization methods using 76 independent BMI-associated SNPs
Number of subjects: 675697

Group type: EXPERIMENTAL
Intervention: Bayesian colocalization methods
Number of subjects: 675697
Study: 35723701

Group type: EXPERIMENTAL
Intervention: Open reduction and internal fixation (ORIF)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Primary arthrodesis (PA)
Number of subjects: 78
Study: 32694374

Group type: EXPERIMENTAL
Intervention: EtOH ingestion (0.1 g·kg lean body mass·h; 30.2 ± 1.1 g 40% ABV Vodka)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (no EtOH ingestion)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: EtOH ingestion
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control
Number of subjects: 8
Study: 35395620

Group type: EXPERIMENTAL
Intervention: Auditory biofeedback (AudFB) during gait training
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no instructions during sessions)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both groups (AudFB and Control)
Number of subjects: 18
Study: 34225722

Group type: EXPERIMENTAL
Intervention: Dyad training
Number of subjects: 41

Group type: COMPARATOR
Intervention: Individual training
Number of subjects: 41
Study: 35821785

Group type: EXPERIMENTAL
Intervention: Licaminlimab (60 mg/mL ophthalmic solution)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 134
Study: 34345965

Group type: EXPERIMENTAL
Intervention: Viable probiotic tablets (Lactobacillus salivarius subsp. salicinius AP‐32, Bifidobacterium animalis subsp. lactis CP‐9, Lactobacillus paracasei ET‐66)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Heat-killed probiotic tablets (Lactobacillus salivarius subsp. salicinius AP‐32, Lactobacillus paracasei ET‐66)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 45
Study: 34586472

Group type: EXPERIMENTAL
Intervention: Leflunomide
Number of subjects: 136

Group type: COMPARATOR
Intervention: Sulfasalazine
Number of subjects: 136
Study: 32441868

Group type: EXPERIMENTAL
Intervention: Insomnia symptoms (self-reported)
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: High non-restorative index (subjective)
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Higher amounts of rapid eye movement (REM) sleep
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Sleep disturbances (self-reported)
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Elevated REM sleep
Number of subjects: 319
Study: 33002731

Group type: EXPERIMENTAL
Intervention: iTBS-γ tACS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: cTBS-γ tACS
Number of subjects: 0

Group type: COMPARATOR
Intervention: iTBS-sham tACS
Number of subjects: 0

Group type: COMPARATOR
Intervention: cTBS-sham tACS
Number of subjects: 0
Study: 35484369

Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy (SLNB)
Number of subjects: 275
Study: 33443913

Group type: EXPERIMENTAL
Intervention: Limberg flap repair
Number of subjects: 234

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 234
Study: 34201821

Group type: EXPERIMENTAL
Intervention: Fortification with multiple micronutrient powder
Number of subjects: 162

Group type: COMPARATOR
Intervention: Standard drug supplementation of ferrous sulfate associated with folic acid
Number of subjects: 162
Study: 32286894

Group type: EXPERIMENTAL
Intervention: Cacao by-products
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 0
Study: 33926835

Group type: EXPERIMENTAL
Intervention: Distal radial artery (dRA) access
Number of subjects: 0

Group type: COMPARATOR
Intervention: Proximal radial artery (pRA) access
Number of subjects: 0